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A bst ract
Primary intracranial squamous cell carcinoma is extremely
rare, with most cases arising from malignant transformation
of dysembryogenetic lesions such as epidermoid and dermoid
cysts. Intracranial squamous cell neoplasm arising de novo is
even rarer and has been reported in only four patients to date.
We herein describe a case of primary intracranial squamous
cell carcinoma arising de novo in the right frontal lobe in 
a 35-year-old woman treated with a combination of surgery
and postoperative conformal radiation. We have also shed
light on the biology and the therapeutic options of this enig-
matic tumour.
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Primary intracranial basaloid squamous cell carcinoma: an enigma
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CASE REPORT/OPIS PRZYPADKU
St r eszc zenie
Pierwotny œródczaszkowy rak p³askonab³onkowy jest wy -
j¹tkow¹ rzadkoœci¹ i w wiêkszoœci przypadków rozwija siê 
w wyniku zez³oœliwienia zmian o charakterze dysembrioge-
netycznym, np. torbieli naskórkowej lub skórzastej. Œród-
czaszkowy rak p³askonab³onkowy powsta³y de novo jest jesz-
cze rzadszy – dot¹d opisano 4 takie przypadki.
W niniejszej pracy przedstawiono przypadek nowotworu
powsta³ego de novo w prawym p³acie czo³owym u 35-letniej
chorej, któr¹ z tego powodu poddano leczeniu chirurgiczne-
mu i pooperacyjnej radioterapii konformalnej. Podano rów-
nie¿ informacje na temat biologii i mo¿liwoœci leczenia tego
zagadkowego guza.
S³owa kluczowe: rak p³askonab³onkowy, œródczaszkowy, baza-
loidalny.
Introduction
Primary intracranial squamous cell carcinoma 
(PISCC) arising de novo is a rarity and has been des -
cribed in only four patients in the available literature.
We have brought into focus the biology and treatment
options of this rare tumour by citing a case of PISCC
arising de novo in the right frontal lobe in a 35-year-old
woman treated successfully with a combination of sur -
gery and postoperative conformal radiation.
Case report
A 35-year-old woman presented to our clinic with
a history of recurrent headache, vomiting and focal
seizures for the last two months. She also complained
of dimness of vision in the left eye for the same dura-
tion. On clinical examination, higher mental function
was found to be normal. Visual acuity in both eyes was
noted to be 6/9. Fundoscopy revealed bilateral early
papilloedema. There were no features of cranial nerve
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palsy or sensorimotor deficit. Contrast-enhanced com-
puted tomography (CT) of the brain showed a lesion in
the right anterior frontal lobe, 4.8 × 4.2 cm in size, with
perifocal oedema, mass effect and ring-like contrast
enhancement. A 2.5 cm enhancing nodule was seen
anterior to the cystic lesion. There was no evidence
of internal calcification. Gadolinium-enhanced magnetic
resonance imaging (MRI) of the brain revealed an
extra-axial lesion with mixed signal intensity and with
solid cystic component in the right frontal lobe, measur-
ing 1.7 × 2.5 × 3.3 cm, with a large right paramedian
cystic component measuring 3.8 × 3.9 × 4.4 cm.
The lesion had a broad base overlying the frontal con-
vexity with subfalcine herniation. Heterogeneous post-
contrast peripheral rim enhancement was noted (Fig. 1).
The patient was referred to the department of neuro-
surgery, where she underwent right frontal craniotomy
and Simpson’s grade II removal of the right basifrontal
tumour. Intraoperative findings included a dural-based
firm relatively avascular extraaxial frontobasal tumour
with attachment to the falx with amber-coloured fluid
in the cystic component. There was no bony erosion and
the tumour could be easily separated from the dura.
The operative diagnosis was right basifrontal menin-
gioma. 
Microscopic examination of the solid component
showed a malignant epithelial tumour arranged in nests
and islands separated by fibrocollagenous septae. There
was squamoid appearance of the tumour cells with pal-
isading of basal cell nuclei. A pseudoglandular pattern
was seen in places. Focal areas showed palisading of
tumour cells. The cyst wall also showed foci of the same
tumour. The various differential diagnoses considered
were basaloid squamous cell carcinoma, meningioma,
metastatic neuroendocrine carcinoma and glial tumour.
Tumour cells were negative for glial fibrillary acidic pro-
tein (GFAP), vimentin, chromogranin and synapto-
physin, thereby excluding the latter three possibilities.
Immunopositivity against pan-cytokeratin, epithelial
membrane antigen (EMA), 34βE12 and p63 antibod-
ies supported the diagnosis of basaloid squamous cell
carcinoma (Fig. 2). Thorough otorhinolaryngological
examination including panendoscopy showed no evi-
dence of disease. A whole body 18 F-FDG positron
emission tomography (PET)-CT scan, performed to
rule out any other primary site of disease, showed uptake
only in the intracranial lesion (Fig. 3). The final impres-
sion was primary intracranial basaloid squamous cell
carcinoma. Subsequently, the patient underwent post-
operative radiation 60 Gy in 30 fractions over 6 weeks
because of subtotal resection of the tumour. Radiation
was planned by three-dimensional conformal technique
(3DCRT) in the Eclipse treatment planning system
(version 6.5) with two non-coplanar fields (right later-
al skull and vertex) and 6 MV photon beams. Radiation
was delivered in 2 phases – initially 50 Gy in 25 frac-
tions over 5 weeks followed by a cone-down boost of
10 Gy in 5 fractions over 1 week. The patient tolerated
treatment well with no major toxicity or unplanned
break. Contrast-enhanced CT scan of the brain per-
formed 6 and 18 months after the completion of treat-
ment showed no evidence of residuum or recurrence.
At the last follow-up, two years after the initial diagno-
sis, the patient was found to be neurologically intact with
no clinical evidence of disease.
Discussion
Intracranial squamous cell carcinoma may arise as
metastatic spread from other squamous cell neoplasms
or direct invasion from head and neck squamous cell
carcinoma. Primary intracranial squamous cell carcino-
ma (PISCC) is a rarity. The majority of PISCCs have
been found to arise by malignant transformation of
a dermoid or epidermoid cyst [1-4]. Intracranial squa-
mous cell carcinoma arising de novo is extremely rare and
only four such cases have been reported in the available
literature (Table 1). 
Over the years, it has been postulated that the PISCC
occurs by malignant transformation of a pre-existing epi-
dermoid or dermoid cyst. The potential mechanisms
include a chronic inflammatory response due to cystic
rupture or subtotal resection of the cyst wall [1,4-6].
Cranial radiation has been associated with the develop-
ment of ISCC in treated cases of craniopharyngioma
[7]. According to Garcia et al. [8], an intracranial squa-
mous cell neoplasm is classified as PISCC only when it
fulfils all of the following criteria: 1) the tumour must
be restricted to the intracranial, intradural compartment
without invasion of, or extension beyond, the dura or
cranial bones; 2) there must be no extension or invasion
through intracranial orifices; 3) there must be no com-
munication or connection with the middle ear, air sinus-
es or sella turcica; and 4) there must be no evidence
of a nasopharyngeal tumour.
Primary intracranial squamous cell carcinoma peaks
in the fourth to fifth decade. A slight male preponder-
ance has been described in the literature [1]. The most
common location is the cerebellopontine angle and most
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Fig. 1. T1-weighted gadolinium-enhanced MRI of the brain (A – axial section; B – sagittal section; C – coronal section) reveals an extra-axial lesion with mixed signal
intensity and with solid cystic component in the right frontal lobe measuring 1.7 × 2.5 × 3.3 cm with a large right paramedian cystic component measuring 
3.8 × 3.9 × 4.4 cm. The lesion has a broad base overlying the frontal convexity with subfalcine herniation. Heterogeneous post-contrast peripheral rim enhance-
ment, midline shift and dilatation of the occipital horn of the left lateral ventricle are noted
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Fig. 2. (A) Tumour arranged in cribriform and pseudoglandular pattern along with palisading of tumour cells (H&E, 200×). (B) Tumour with squamous differentia-
tion (H&E, 400×). Overall features are those of basaloid squamous cell carcinoma. (C) Immunopositivity against 34βE12 (400×). (D) Immunopositivity against
p63 (400×)
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cases arise from pre-existing benign epidermoid or der-
moid cysts [1,4,9,10]. Primary intracranial squamous
cell carcinoma, because of its typical location, presents
with features of cerebellopontine angle compression.
Severe headache because of cerebrospinal fluid block-
ade is the most important presenting feature. Other
neurological symptoms may be attributed to the tumour
location and extension. As evidenced in other CNS
malignancies, contrast enhanced MRI is the investiga-
tion of choice. Recent introduction of diffusion-weight-
ed imaging (DWI) has been found to be extremely
helpful in differentiating PISCC from other benign
cysts. Benign cysts have very high signal intensity on
DWI, whereas a highly malignant transformation will
show low signal intensity on DWI and a ring-like en -
hancement on T1-weighted MRI after gadolinium
A
Fig. 3. (A) Whole body 18F-fluorodeoxyglucose (FDG) PET-CT scan shows no evidence of extracranial primary lesion. (B) Postoperative cavity in the right frontal lobe
with residuum in the right basifrontal region showing mild FDG uptake (arrow)
B
No. Author Age Tumour Histopathology Autopsy Tumour Treatment Outcome Survival 
[years]/ sex location origin
1 Nosaka 46/M CP angle SCC SCC Unknown Surgery Dead Overall survival 
et al. [14] – 7 months
2 Garcia 61/M CP angle SCC SCC Unknown Surgery → Dead Overall survival 
et al. [8] Post-op RT – 9 months
3 Ebisudani 68/M CP angle SCC SCC Unknown Surgery Dead Overall survival 
et al. [15] – 1 month
4 Jain 5/F Right Poorly – Unknown Surgery → Local Relapse-free 
et al. [12] temporal differentiated ChT → RT recurrence survival
lobe adenosquamous – 10 months
carcinoma 
(prominent SCC 
component)
5 Present 35/F Right Basaloid – Unknown Surgery → Disease Overall survival 
case frontal lobe SCC Post-op RT free – 24 months
Table 1. Cases of primary intracranial squamous cell carcinoma arising de novo – a summary
M – male; F – female; CP – cerebellopontine; SCC – squamous cell carcinoma; ChT – chemotherapy; RT – radiotherapy
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injection [4,11]. CT without contrast enhancement can
reveal calcifications in PISCC arising from remnants
of epidermoid cysts [12].
Surgery remains the mainstay of treatment and has
been used in the majority of cases. Location in close
proximity to the brain stem or cerebellopontine angle,
and adherence to brain parenchyma and cerebral blood
vessels, often preclude a complete resection, however.
Patients who undergo incomplete surgery merit further
treatment in the form of postoperative radiotherapy.
The existing literature shows that patients with PISCC
have a very poor prognosis and median survival with
surgery alone is around 9 months. Addition of adjuvant
radiation may improve the outcome and prolong the
median survival to as long as two years [2,5]. However,
a consensus regarding optimal radiotherapy time-dose-
fractionation in PISCC is lacking because of the rarity
of the disease.
Taking a cue from our clinical experience in post-
operative radiotherapy in head and neck squamous cell
carcinoma, we have prescribed a dose of 60 Gy in 
30 frac tions over a period of 6 weeks in the index patient.
Intensity-modulated radiotherapy and stereotactic radio-
therapy have been used as different me thods of radia-
tion delivery in PISCC. A few reports have emphasized
the usefulness of gamma knife radiosur gery of postop-
erative residuum [1,13]. However, keeping in mind
the various logistic constraints in a de veloping nation,
we have used three-dimensional conformal radiothera-
py. Clinical target volume (CTV) was defined as 1 cm
uniform expansion encompassing the pre-operative
tumour volume and perifocal oedema discerned on T1-
weighted post-contrast and T2-weighted MR images,
respectively. A further isotropic expansion of 5 mm was
given to the CTV to form the planning target volume
to account for set-up error and intrafraction motion.
Chemotherapy has been used in some of the avail-
able reports in the form of intrathecal methotrexate.
Murase et al. [1] used three courses of chemotherapy
with the VMP-F regimen (vincristine, methotrexate,
peplomycin and calcium folinate), a common regimen
used in the management of cutaneous squamous cell car-
cinoma in Japan in the 1990s. Jain et al. [12] used four
cycles of chemotherapy with cisplatin, VP-16, and ifos-
famide followed by two cycles of dose-intensified cy -
clophosphamide and carboplatin with autologous stem
cell rescue. But the response achieved was transient. Due
to lack of conclusive evidence regarding the efficacy
of chemotherapy in PISCC and minimal central ner-
vous system penetration of the commonly used che mo -
therapeutics in squamous cell neoplasm, we refrained
from using chemotherapy in the index patient.
In the available reports on PISCC arising de novo
[8,12,14,15] (Table 1), the age at presentation varied
from 5 to 68 years with a male to female ratio of 3 : 2.
The most common location was the cerebellopontine
angle. Surgery was the cornerstone of treatment, with
post-operative radiotherapy and chemotherapy being
used in 3 and 1 patient, respectively. Prognosis was uni-
formly poor with relentless disease progression within 
6 months. The illustrative case is notable in being the
first case of PISCC arising de novo in the frontal lobe,
successfully treated with a combination of surgery and
post-operative radiation with no evidence of disease 
2 years after diagnosis.
In spite of its intricate anatomy, the human brain is
essentially composed of neurons, the basic cells of the
nervous system, and the neuroglial cells forming sup-
portive tissue, all enclosed in three layers of connective
tissue – the meninges. In a landscape which is so devoid
of any presence of epithelium, evolution of PISCC is
indeed intriguing. The majority of cases of PISCC arise
by malignant transformation of dysembryogenetic lesions
such as epidermoid and dermoid cysts, craniopharyn-
gioma, etc. How can an intracranial squamous cell car-
cinoma arise de novo? The possibility of development
from a pre-existing benign lesion, which has remained
asymptomatic and undiagnosed until malignant pro-
gression, should be considered. In view of the fronto-
basal location of the tumour and proximity to the pa -
ranasal sinus, occult squamous cell carcinoma of the
paranasal sinus with intracranial extension through
the base of the skull is a distant possibility. However, it
is extremely unlikely that an initially occult squamous
cell carcinoma of the paranasal sinus with intracranial
extension would remain silent for 2 years when only
the intracranial part has been oncologically addressed.
Conclusion
Given the rarity of PISCC, the optimal treatment is
largely undefined. Maximal safe resection followed by
adjuvant radiotherapy is probably the best option. In
spite of the poor prognosis associated with PISCC, such
an approach might lead to a reasonable disease-free pe -
riod, as seen in the illustrative case.
Disclosure
Authors report no conflict of interest.
Supriya Mallick, Ahitagni Biswas, Narender Kumar, Mehar Chand Sharma, Rakesh Kumar, Rama Mohan Reddy, Pramod Kumar Julka, Goura Kishore Rath
Neurologia i Neurochirurgia Polska 2012; 46, 5 495
Primary intracranial basaloid squamous cell carcinoma
References
1. Murase S., Yamakawa H., Ohkuma A., et al. Primary intra cra -
nial squamous cell carcinoma. Neurol Med Chir (Tokyo) 1999;
39: 49-54.
2. Nishio S., Takeshita I., Morioka T., et al. Primary intracranial
squamous cell carcinomas: report of two cases. Neurosurgery
1995; 37: 329-332.
3. Kobayashi T., Kuchiwaki H., Inao S., et al. A squamous cell car -
cinoma originated from intracranial dermoid cyst. Neurochirurgia
1993; 36: 26-29.
4. Kim M.S., Kim O.L. Primary intracranial squamous cell car -
cinoma in brainstem with a cerebellopontine angle epidermoid
cyst. J Korean Neurosurg Soc 2008; 44: 401-404.
5. Hamlat A., Hua Z.F., Saikali S., et al. Malignant transformation
of intracranial epidermoid cyst with leptomeningeal carcino -
matosis: case report. Acta Neurol Belg 2003; 103: 221-224.
6. Abramson R.C., Morawetz R.B., Schlitt M. Multiple compli -
cations from an intracranial epidermoid cyst: case report and
literature review. Neurosurgery 1989; 24: 574-578.
7. Kristopaitis T., Thomas C., Petruzzelli G.J., et al. Malignant cra -
niopharyngioma. Arch Pathol Lab Med 2000; 124: 1356-1360.
8. Garcia C.A., McGarry P.A., Rodriguez F. Primary intracranial
squamous cell carcinoma of the right cerebellopontine angle. 
J Neurosurg 1981; 54: 824-828.
9. Guan L.M., Qi X.X., Zhang J.R., et al. Intracranial squamous
cell carcinoma developing in remnant of an epidermoid cyst: 
case report and literature review. Chin Med J (Engl) 2004; 117:
1880-1883.
10. Tamura K., Aoyagi M., Wakimoto H., et al. Malignant trans -
formation eight years after removal of a benign epidermoid cyst:
a case report. J Neurooncol 2006; 79: 67-72.
11. Nawashiro H., Higo R., Tokumaru A.M., et al. Diffusion-
weighted MRI of an intracranial epidermoid with malignant
transformation. Neuroradiology 2001; 43: 891.
12. Jain R., Gujar S., McKeever P., et al. Imaging findings associated
with childhood primary intracranial squamous cell carcinoma.
Am J Neuroradiol 2003; 24: 109-111.
13. Mori Y., Suzuki Y., Tanasawa J., et al. A case report of epi -
dermoid carcinoma in cerebellopontine angle. No Shinkei Geka
1995; 23: 905-909.
14. Nosaka Y., Nagao S., Tabuchi K., et al. Primary intracranial epi -
dermoid carcinoma. J Neurosurg 1979; 50: 830-833.
15. Ebisudani D., Hamazaki F., Oka H., et al. An autopsy case
of primary intracranial squamous cell carcinoma. No Shinkei Geka
1990; 18: 193-198.
